Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
about
Safety of Novel Microbes for Human Consumption: Practical Examples of Assessment in the European Union.The contribution of microbial biotechnology to sustainable development goals: microbiome therapies.Emerging Trends in "Smart Probiotics": Functional Consideration for the Development of Novel Health and Industrial ApplicationsComplete Genome Sequence of Eubacterium hallii Strain L2-7.Effect of cryopreservation and lyophilization on viability and growth of strict anaerobic human gut microbes.In Vitro Modeling of Bile Acid Processing by the Human Fecal Microbiota.
P2860
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@ast
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@en
type
label
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@ast
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@en
prefLabel
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@ast
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.
@en
P2093
P2860
P50
P1476
Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice
@en
P2093
Albert K Groen
Clara Belzer
Erik S G Stroes
Harry J Flint
Hilde Herrema
Louise Manneras-Holm
Max Nieuwdorp
Shanthadevi Udayappan
Silvia H Duncan
Willem M de Vos
P2860
P2888
P356
10.1038/NPJBIOFILMS.2016.9
P577
2016-07-06T00:00:00Z
P6179
1004036587